These benefits, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assistance the strategy of concentrating on ACKR3 as a singular strategy to modulate the opioid system, which could open up new therapeutic avenues for opio